These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31064849)

  • 1. PGC1α Inhibits Polyamine Synthesis to Suppress Prostate Cancer Aggressiveness.
    Kaminski L; Torrino S; Dufies M; Djabari Z; Haider R; Roustan FR; Jaune E; Laurent K; Nottet N; Michiels JF; Gesson M; Rocchi S; Mazure NM; Durand M; Tanti JF; Ambrosetti D; Clavel S; Ben-Sahra I; Bost F
    Cancer Res; 2019 Jul; 79(13):3268-3280. PubMed ID: 31064849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGC1α Suppresses Prostate Cancer Cell Invasion through ERRα Transcriptional Control.
    Valcarcel-Jimenez L; Macchia A; Crosas-Molist E; Schaub-Clerigué A; Camacho L; Martín-Martín N; Cicogna P; Viera-Bardón C; Fernández-Ruiz S; Rodriguez-Hernandez I; Hermanova I; Astobiza I; Cortazar AR; Corres-Mendizabal J; Gomez-Muñoz A; Sanz-Moreno V; Torrano V; Carracedo A
    Cancer Res; 2019 Dec; 79(24):6153-6165. PubMed ID: 31594836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGC1α drives a metabolic block on prostate cancer progression.
    Wallace M; Metallo CM
    Nat Cell Biol; 2016 May; 18(6):589-90. PubMed ID: 27230528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGC1α promotes cholangiocarcinoma metastasis by upregulating PDHA1 and MPC1 expression to reverse the Warburg effect.
    Dan Li ; Wang C; Ma P; Yu Q; Gu M; Dong L; Jiang W; Pan S; Xie C; Han J; Lan Y; Sun J; Sheng P; Liu K; Wu Y; Liu L; Ma Y; Jiang H
    Cell Death Dis; 2018 May; 9(5):466. PubMed ID: 29700317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPC1, a key gene in cancer metabolism, is regulated by COUPTFII in human prostate cancer.
    Wang L; Xu M; Qin J; Lin SC; Lee HJ; Tsai SY; Tsai MJ
    Oncotarget; 2016 Mar; 7(12):14673-83. PubMed ID: 26895100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53/PGC‑1α‑mediated mitochondrial dysfunction promotes PC3 prostate cancer cell apoptosis.
    Li J; Li Y; Chen L; Yu B; Xue Y; Guo R; Su J; Liu Y; Sun L
    Mol Med Rep; 2020 Jul; 22(1):155-164. PubMed ID: 32377739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.
    Torrano V; Valcarcel-Jimenez L; Cortazar AR; Liu X; Urosevic J; Castillo-Martin M; Fernández-Ruiz S; Morciano G; Caro-Maldonado A; Guiu M; Zúñiga-García P; Graupera M; Bellmunt A; Pandya P; Lorente M; Martín-Martín N; Sutherland JD; Sanchez-Mosquera P; Bozal-Basterra L; Zabala-Letona A; Arruabarrena-Aristorena A; Berenguer A; Embade N; Ugalde-Olano A; Lacasa-Viscasillas I; Loizaga-Iriarte A; Unda-Urzaiz M; Schultz N; Aransay AM; Sanz-Moreno V; Barrio R; Velasco G; Pinton P; Cordon-Cardo C; Locasale JW; Gomis RR; Carracedo A
    Nat Cell Biol; 2016 Jun; 18(6):645-656. PubMed ID: 27214280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP-Citrate Lyase Epigenetically Potentiates Oxidative Phosphorylation to Promote Melanoma Growth and Adaptive Resistance to MAPK Inhibition.
    Guo W; Ma J; Yang Y; Guo S; Zhang W; Zhao T; Yi X; Wang H; Wang S; Liu Y; Dai W; Chen X; Shi Q; Wang G; Gao T; Li C
    Clin Cancer Res; 2020 Jun; 26(11):2725-2739. PubMed ID: 32034077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A PGC1α-mediated transcriptional axis suppresses melanoma metastasis.
    Luo C; Lim JH; Lee Y; Granter SR; Thomas A; Vazquez F; Widlund HR; Puigserver P
    Nature; 2016 Sep; 537(7620):422-426. PubMed ID: 27580028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLCε regulates prostate cancer mitochondrial oxidative metabolism and migration via upregulation of Twist1.
    Fan J; Fan Y; Wang X; Niu L; Duan L; Yang J; Li L; Gao Y; Wu X; Luo C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):337. PubMed ID: 31383001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OLR1 Promotes Pancreatic Cancer Metastasis via Increased c-Myc Expression and Transcription of HMGA2.
    Yang G; Xiong G; Feng M; Zhao F; Qiu J; Liu Y; Cao Z; Wang H; Yang J; You L; Zheng L; Zhang T; Zhao Y
    Mol Cancer Res; 2020 May; 18(5):685-697. PubMed ID: 32019809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional Repression of SIRT3 Potentiates Mitochondrial Aconitase Activation to Drive Aggressive Prostate Cancer to the Bone.
    Sawant Dessai A; Dominguez MP; Chen UI; Hasper J; Prechtl C; Yu C; Katsuta E; Dai T; Zhu B; Jung SY; Putluri N; Takabe K; Zhang XH; O'Malley BW; Dasgupta S
    Cancer Res; 2021 Jan; 81(1):50-63. PubMed ID: 33115805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The c-myc gene regulates the polyamine pathway in DMSO-induced apoptosis.
    Trubiani O; Pieri C; Rapino M; Di Primio R
    Cell Prolif; 1999; 32(2-3):119-29. PubMed ID: 10535358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis.
    Han J; Zhang Y; Xu J; Zhang T; Wang H; Wang Z; Jiang Y; Zhou L; Yang M; Hua Y; Cai Z
    Cancer Lett; 2021 Jan; 496():57-71. PubMed ID: 33038488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming.
    Xu L; Wang L; Zhou L; Dorfman RG; Pan Y; Tang D; Wang Y; Yin Y; Jiang C; Zou X; Wu J; Zhang M
    Neoplasia; 2019 May; 21(5):429-441. PubMed ID: 30933885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wedelolactone, an Anti-inflammatory Botanical, Interrupts c-Myc Oncogenic Signaling and Synergizes with Enzalutamide to Induce Apoptosis in Prostate Cancer Cells.
    Sarveswaran S; Ghosh R; Parikh R; Ghosh J
    Mol Cancer Ther; 2016 Nov; 15(11):2791-2801. PubMed ID: 27474149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer.
    Pan H; Zhu Y; Wei W; Shao S; Rui X
    World J Surg Oncol; 2018 Mar; 16(1):59. PubMed ID: 29554906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications.
    Tan Z; Luo X; Xiao L; Tang M; Bode AM; Dong Z; Cao Y
    Mol Cancer Ther; 2016 May; 15(5):774-82. PubMed ID: 27197257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of c-MYC and polyamine metabolism in multiple drug resistance in bladder cancer investigated by metabonomics.
    Zhu Y; Piao C; Zhang Z; Jiang Y; Kong C
    Genomics; 2022 Jan; 114(1):125-137. PubMed ID: 34843906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGC1α regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback.
    Shen L; Zhou L; Xia M; Lin N; Ma J; Dong D; Sun L
    Exp Cell Res; 2021 Jan; 398(1):112369. PubMed ID: 33220258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.